FDA End-of-Year Release of Warning Letters Impresses (or Depresses)
FDA Law Blog
JANUARY 1, 2024
If FDA wanted to create that impression, it likely succeeded. Warning Letters, generally made public in a batch each Tuesday, are FDA’s public sanction that is most widely used to bring pressure on manufacturers and clinical trial investigators. FDA stated that the firm received 96 U.S. Dextrum Laboratories Inc.
59 
Let's personalize your content